Compare LEDS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEDS | CRIS |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 14.0M |
| IPO Year | 2010 | 2000 |
| Metric | LEDS | CRIS |
|---|---|---|
| Price | $1.19 | $0.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 8.3K | ★ 109.1K |
| Earning Date | 04-09-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.12 | 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $43,009,000.00 | $9,898,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 729.81 | 31.50 |
| 52 Week Low | $1.31 | $0.77 |
| 52 Week High | $3.37 | $3.13 |
| Indicator | LEDS | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 25.70 | 29.02 |
| Support Level | N/A | N/A |
| Resistance Level | $2.02 | $1.04 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 12.15 | 4.08 |
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.